These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32385806)

  • 21. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients.
    Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z
    Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.
    Merkely B; Kosztin A; Roka A; Geller L; Zima E; Kovacs A; Boros AM; Klein H; Wranicz JK; Hindricks G; Clemens M; Duray GZ; Moss AJ; Goldenberg I; Kutyifa V
    Europace; 2017 Sep; 19(9):1549-1555. PubMed ID: 28339581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?
    van Everdingen WM; Zweerink A; Salden OAE; Cramer MJ; Doevendans PA; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Europace; 2019 Jan; 21(1):e11-e19. PubMed ID: 30052906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
    Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy.
    Gold MR; Leman RB; Wold N; Sturdivant JL; Yu Y
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):624-30. PubMed ID: 24446891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization Therapy.
    Lee AW; Crozier A; Hyde ER; Lamata P; Truong M; Sohal M; Jackson T; Behar JM; Claridge S; Shetty A; Sammut E; Plank G; Rinaldi CA; Niederer S
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):208-215. PubMed ID: 27885749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of cardiac resynchronization therapy: importance of programmed parameters.
    Cuoco FA; Gold MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):110-8. PubMed ID: 22188487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.
    Singh JP; Cha YM; Lunati M; Chung ES; Li S; Smeets P; O'Donnell D
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):825-833. PubMed ID: 32009263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting.
    Laish-Farkash A; Bruoha S; Katz A; Goldenberg I; Suleiman M; Michowitz Y; Shlomo N; Einhorn-Cohen M; Khalameizer V
    Europace; 2017 Aug; 19(8):1357-1363. PubMed ID: 27733457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impedance cardiography: a useful and reliable tool in optimization of cardiac resynchronization devices.
    Heinroth KM; Elster M; Nuding S; Schlegel F; Christoph A; Carter J; Buerke M; Werdan K
    Europace; 2007 Sep; 9(9):744-50. PubMed ID: 17496288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.
    Arbelo E; Tolosana JM; Trucco E; Penela D; Borràs R; Doltra A; Andreu D; Aceña M; Berruezo A; Sitges M; Mansour F; Castel A; Matas M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):283-92. PubMed ID: 24237881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.